Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Trial Comparing Swallowed Topical Budesonide With Subcutaneous Dupilumab on Esophageal Diameter and Fibrotic Change in Eosinophilic Esophagitis

NCT07358234 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07358234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07358234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Trial Comparing Swallowed Topical Budesonide With Subcutaneous Dupilumab on Esophageal Diameter and Fibrotic Change in Eosinophilic Esophagitis
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
February 4, 2026
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis (eoe)